SciBase introduces Nevisense View – integrating images in

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 31, 2016 at 2:15 AM

SciBase introduces Nevisense View – integrating images in the fight against malignant melanoma

With its new instrument, Nevisense View, SciBase combines its patented electrical impedance spectroscopy (EIS) for early detection of malignant melanoma with visual information from digital dermascopy, creating a complete instrument that can both improve and simplify the diagnostic process. Malignant melanoma is the most threatening form of skin cancer and is behind 75 percent of all skin cancer deaths. The key to successful treatment of malignant melanoma is early discovery, since this aggressive form of cancer can quickly spread throughout the body. The cancer is often difficult to detect, and digital dermascopy is one of the methods used for detection. This method is based on visual evaluations of skin lesions using a dermascope, while hard-to-diagnose cases often make use of short term digital dermoscopy imaging (SDDI) to compare pictures of lesions that have changed over time. SciBase is now integrating the digital dermascopy method into its new product and combining it with EIS technology, which uses electrical impulses to detect abnormal cell structures that could be a sign of malignant melanoma. Furthermore, SciBase’s new instrument also simplifies the process for performing skin examinations since all information from the exam is saved in the same instrument. The ability to track the changes of a suspicious lesion, both using EIS values and images, helps prevent both the unnecessary removal of benign tissue and helps avoid malignant melanoma going undetected during an examination. “According to a new study, conducted by researchers from Melanoma Institute of Australia and Royal Prince Alfred Hospital in Sydney, the use of EIS can reduce the number of cases that need to be followed up using SDDI by almost half, and may also allow for early detection of malignant melanoma three months earlier than traditional methods,” says Simon Grant, CEO of SciBase. “Being able to combine these two methods into one product and present it in conjunction with a study that supports our method at the World Congress on Cancers of the Skin in Vienna on August 31 is of course a milestone in the company’s history,” says Simon. Nevisense View simplifies caregivers’ work by offering the following functions: · Wireless transfer of images to Nevisense · Combination of EIS, image and patient information as a PDF report for full documentation of the examination. · Easy-to-use follow-up functions, such as a shared screen for being able to compare lesions over time. Nevisense View will be available in Sweden and in SciBase’s other markets in November. More information about the study can be found here: Swedish Nevisense can reduce follow up visits by half for difficult-to-diagnose skin changes in melanoma detection (http://investors.scibase.se/en/new-study-swedish-nevisense -can-reduce-follow-up-visits-by-half-for-difficult-to-diagnose-lesions-in) For more information, please contact: Simon Grant, CEO Phone: +46 72 887 43 99 Email: simon.grant@scibase.com This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on August 31, 2016. About Skin Cancer Skin cancer is one of the most common cancers in the world, accounting for nearly half of all cancers. It has been estimated that nearly half of all Americans who live to the age of 65 will develop skin cancer at least once. Malignant melanoma is the most fatal form of skin cancer causing the majority (75%) of deaths related to skin cancer. Worldwide, doctors diagnose about 230,000 new cases of melanoma yearly. About SciBase and Nevisense SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed a unique point-of-care device for the accurate detection of malignant melanoma. Its product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase was founded by Stig Ollmar, Associate Professor at The Karolinska Institute in Stockholm, Sweden. Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. Nevisense is CE marked in Europe, has TGA approval in Australia, and is awaiting FDA clearance in the United States. Nevisense is based on a method called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and thereby detect malignancies. SciBase is listed on Nasdaq First North (“SCIB”). Avanza is the certified advisor. Further information is available on www.scibase.com.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

21st.BIO Seeks EU Nod for Precision Fermentation Tech

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Aristocrat's Leadership Shift: Croker to Guisard in 2027

Aristocrat's Upcoming Change at the Helm Shuffling the deck at the top can make or break a ship. Aristocrat is swapping its captain as Trevor Croker steps down, and they're betting Dafne Guisard's got the wind in her sails to ride the next wave. This ain't your average CEO transition, either—it's got a whole year of easing into the reins. The Decision to Appoint Guisard...

Global Challenge: A New Era for AI Web Agents

By Riley Hayes Updated Nov 12, 2026 Category News Views 118

The Dawn of the Agent Web Well, here we are, standing at the cusp of a new digital frontier, folks. This ain't just another buzzword parade; this is the Open Agentic Web Challenge, courting developers with a $13K carrot to craft an interoperable playground for AI agents. Big names like Cognizant AI Lab, MIT Media Lab, and others are leading the charge. No small-time...

Reolink Slashes Prices for Black Friday Bonanza

Security Steals: Navigating Reolink's Festive Deals Well, folks, if you're in the market for sprucing up your security game, this might just be your lucky season. Reolink, a name folks trust when it comes to security gadgets, is dropping the hammer with some serious Black Friday and Cyber Monday discounts. Starting November 12, they're setting the stage for nearly three...

Clean Tech's Dual Role: Energy Resilience and Dependency

Technology's Double-Edged Sword in Energy You ever chat with someone about moving your whole life onto solar? Seems greener and cheaper, right? But dive into the numbers, and you'll see it comes with its own set of strings attached. According to a fresh-off-the-press report from S&P Global, clean tech is both a saving grace and a looming liability economically and...

Lucas Bols: A Legacy Crowned A 450-year-old legacy finally gets its due with the Lucas Bols Company snagging the "Spirit Brand of the Year" title from Wine Enthusiast. This ain’t just another pat on the back; it's a serious nod to a brand that’s been laying down the cocktail foundation long before some countries even existed. Across the past five centuries, they've...

FCM Travel Names New CPO to Lead AI Innovation

Fresh Face at the Helm Hiring Mark McSpadden as Chief Product Officer is a move by FCM Travel that signals the company's intent to deepen its roots in tech and innovation within the corporate travel sector. There's no subtlety here—FCM's making a bold statement, and they're throwing serious weight behind their tech strategy. Don’t take this lightly; this is them...

THE HONEST FARMER Risks Launch into China's Market

THE HONEST FARMER Challenges Mainland China Okay, let's tackle this little tangent in the ever-evolving saga of food exports. THE HONEST FARMER Co., Ltd., a name probably unfamiliar to many unless you're tuning into South Korea's food manufacturing scene, is stirring the pot by diving into unfamiliar waters—mainland China. They're leaning heavily on their in-house...

Southwest Airlines' 191st Quarterly Dividend: A Steady Flight

Another Dividend in Southwest’s Long-Running Playbook Well, here we go again, folks. Southwest Airlines (NYSE: LUV) has just waved the flag on their 191st quarterly dividend like clockwork, pegged at $0.18 per share. If you’re into steady-as-she-goes stock scenarios, this is your scene. On December 17, 2026, registered shareholders are gonna see that little bump in...

Hornets Expand 5G Network Across New Performance Center

Boosting Connectivity with Boldyn Networks Well, the Charlotte Hornets are making moves, folks—beyond just the basketball court. Their play isn't a buzzer-beater this time but a calculated strategy to slap a 5G facelift onto their domain. Partnering with Boldyn Networks, they've spun a web of high-performance cellular sparks across both the Spectrum Center and their...